{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:31:00Z","timestamp":1787509860516,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.99984","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:21:13Z","timestamp":1766564473000},"source":"Crossref","is-referenced-by-count":1,"title":["Fatal Flaw in the Folate Pathway: Methotrexate-Bactrim Interaction, Misleading Levels, and a Cautionary Case"],"prefix":"10.7759","author":[{"given":"Shaivya","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein BN","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020, 16:145-54. 10.1038\/s41584-020-0373-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.45132","article-title":"Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease","volume":"6","author":"Muanda FT","year":"2023","unstructured":"Muanda FT, Blake PG, Weir MA, et al.. Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease. JAMA Netw Open. 2023, 6:e2345132. 10.1001\/jamanetworkopen.2023.45132","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83351-7","article-title":"Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia","volume":"117","author":"Ferrazzini G","year":"1990","unstructured":"Ferrazzini G, Klein J, Sulh H, et al.. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia. J Pediatr. 1990, 117:823-6. 10.1016\/S0022-3476(05)83351-7","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5339\/qmj.2023.31","article-title":"Low serum level and chronic toxicity for methotrexate. Case report","volume":"2023","author":"Musameh I","year":"2023","unstructured":"Musameh I, Al-Bakri F, Ezzeldin A. Low serum level and chronic toxicity for methotrexate. Case report. Qatar Med J. 2023, 2023:31. 10.5339\/qmj.2023.31","journal-title":"Qatar Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586361","article-title":"Adverse drug reactions related to methotrexate: a real-world pharmacovigilance study using the FAERS database from 2004 to 2024","volume":"16","author":"Liu S","year":"2025","unstructured":"Liu S, Yuan Z, Rao S, et al.. Adverse drug reactions related to methotrexate: a real-world pharmacovigilance study using the FAERS database from 2004 to 2024. Front Immunol. 2025, 16:1586361. 10.3389\/fimmu.2025.1586361","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12060","article-title":"Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination","volume":"38","author":"Al-Quteimat OM","year":"2013","unstructured":"Al-Quteimat OM, Al-Badaineh MA. Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination. J Clin Pharm Ther. 2013, 38:203-5. 10.1111\/jcpt.12060","journal-title":"J Clin Pharm Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard SC","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016, 21:1471-82. 10.1634\/theoncologist.2015-0164","journal-title":"Oncologist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.027","article-title":"Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients","volume":"13","author":"Kivity S","year":"2014","unstructured":"Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. Autoimmun Rev. 2014, 13:1109-13. 10.1016\/j.autrev.2014.08.027","journal-title":"Autoimmun Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05989-y","article-title":"Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study","volume":"45","author":"Patil H","year":"2025","unstructured":"Patil H, Prasad S, Subramanian R, Mamadapur M, Nikhil R, Paul AA. Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study. Rheumatol Int. 2025, 45:235. 10.1007\/s00296-025-05989-y","journal-title":"Rheumatol Int"},{"key":"ref10","article-title":"Leucovorin","author":"Hegde VS","year":"2025","unstructured":"Hegde VS, Nagalli S. Leucovorin. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03054-2","article-title":"Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity - a randomized controlled trial","volume":"25","author":"Bhargava M","year":"2023","unstructured":"Bhargava M, Kopp CR, Naidu S, et al.. Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity - a randomized controlled trial. Arthritis Res Ther. 2023, 25:82. 10.1186\/s13075-023-03054-2","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-11-199412010-00002","article-title":"Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial","volume":"121","author":"Morgan SL","year":"1994","unstructured":"Morgan SL, Baggott JE, Vaughn WH, et al.. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med. 1994, 121:833-41. 10.7326\/0003-4819-121-11-199412010-00002","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442008-fatal-flaw-in-the-folate-pathway-methotrexate-bactrim-interaction-misleading-levels-and-a-cautionary-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:21:14Z","timestamp":1766564474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442008-fatal-flaw-in-the-folate-pathway-methotrexate-bactrim-interaction-misleading-levels-and-a-cautionary-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.99984","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}